Lesaffre, an independent key global player in fermentation and microorganisms, announces today the closing of a transaction with dsm-firmenich, a leading innovator in nutrition, health, and beauty, regarding its yeast extract business.
Through this acquisition, Lesaffre solidifies its commitment to growth and innovation within the savory ingredients market. This strategic move enables Biospringer, a Lesaffre’s Business Unit, a global provider of innovative natural origin solutions from yeast fermentation, to integrate dsm-firmenich’s yeast derivatives processing technologies, 46 dsm-firmenich employees working on yeast extracts, and innovative products. It will enhance its ability to serve its customers in savory and other fermentation-based applications.
Lesaffre, headquartered in Marcq-en-Baroeul (France), has established itself as a leader in biomanufacturing, with strong expertise in local culture, consumer tastes and market trends. New customers for Biospringer by Lesaffre will gain access to its global manufacturing network and local supply and sales, ensuring continued growth and success.
The integration process will begin immediately, with Lesaffre and dsm-firmenich working closely to ensure a smooth transition for employees, customers, and partners. Both companies remain committed to delivering the highest quality products and services throughout the transition period and beyond.
dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam.